Accumulation of extracellular matrix (ECM) in liver fibrosis is associated with changes in protein abundance and composition depending upon etiology of the underlying liver disease. Current efforts to ...
A pneumonia cough may sound deeper or louder than other coughs, and you may notice dryness or phlegm. But it also depends on ...
The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...
Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...
In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...
Explore the serious risks of long COVID and its potential impact on health. Can lingering symptoms from COVID-19 be fatal?
This review discussed experimental mouse models used in the pre-clinical study of liver fibrosis regression, a pivotal ...
Patients with cystic fibrosis experience significant bone mineral density loss at a younger age than those without the disease.
MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases: Danbury, Connecticut Tuesday, November 5, 2024, 16:00 Hrs [IST] MannKind Corporation, a company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback